While most previous studies have focused on the cancer itself and aberrant HLA-G expression has been repeatedly observed in various malignant lesions, few studies have reported weak or absent HLA-G expression in peritumoral tissues (PTTs) (6, 23). This evidence concerns the gene HLA-G and cancer.